Citalopram hydrochloride

(R)-Desmethyl Citalopram Hydrochloride is a metabolite of Citalopram . Citalopram is a selective inhibitor of the 5-hydroxytryptamine transporter (serotonin) and therefore is a potent and selective SR (serotonin reuptake) inhibitor. Additional

General description Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Citalopram

The Cinnabar spray chamber is a mini-cyclonic spray chamber which gives good sensitivity at very low uptakes. The Cinnabar's design and low volume is ideal for the reduction of memory and matrix effects and very fast washout.

3-Oxo Citalopram is an intermediate of Citalopram . Citalopram is a selective inhibitor of the 5-hydroxytryptamine transporter (serotonin) and therefore is a potent and selective serotonin reuptake inhibitor. Additional studies in indicate that

653-47 hydrochloride, a potentiator, significantly potentiates the cAMP-response element binding protein (CREB) inhibitory activity of 666-15. 653-47 hydrochloride is also a very weak CREB inhibitor with IC 50 of 26.3 μM.In Vitro653-47 (5-10 μM)

653-47 hydrochloride, a potentiator, significantly potentiates the cAMP-response element binding protein (CREB) inhibitory activity of 666-15. 653-47 hydrochloride is also a very weak CREB inhibitor with IC 50 of 26.3 μM.In Vitro653-47 (5-10 μM)

653-47 hydrochloride, a potentiator, significantly potentiates the cAMP-response element binding protein (CREB) inhibitory activity of 666-15. 653-47 hydrochloride is also a very weak CREB inhibitor with IC 50 of 26.3 μM.In Vitro653-47 (5-10 μM)

653-47 hydrochloride, a potentiator, significantly potentiates the cAMP-response element binding protein (CREB) inhibitory activity of 666-15. 653-47 hydrochloride is also a very weak CREB inhibitor with IC 50 of 26.3 μM.In Vitro653-47 (5-10 μM)

InformationBAR502 is a dual agonist with IC50 of 2 μM and 0.4 μM for FXR and GPBAR1, respectively.

BrBzGCp2 is a Glyoxalase 1 (GLO1) inhibitor, with a GC 50 of 4.23 μM in HL-60 cells. BrBzGCp2 possesses antitumor and neuroprotective activityIn VivoGLO1 inhibition by BrBzGCp2 increases center time in the OF test, without changing distance

BrBzGCp2 is a Glyoxalase 1 (GLO1) inhibitor, with a GC 50 of 4.23 μM in HL-60 cells. BrBzGCp2 possesses antitumor and neuroprotective activityIn VivoGLO1 inhibition by BrBzGCp2 increases center time in the OF test, without changing distance

BrBzGCp2 is a Glyoxalase 1 (GLO1) inhibitor, with a GC 50 of 4.23 μM in HL-60 cells. BrBzGCp2 possesses antitumor and neuroprotective activityIn VivoGLO1 inhibition by BrBzGCp2 increases center time in the OF test, without changing distance